首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity
【24h】

Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity

机译:在瑞士建立门诊肠胃外抗菌治疗(OPAT)单元:对活动的前18个月进行回顾

获取原文
获取原文并翻译 | 示例
       

摘要

Outpatient parenteral antimicrobial therapy (OPAT) has been recognised as a useful, cost-effective and safe alternative to inpatient treatment, but no formal OPAT unit existed in Switzerland until recently. In December 2013 an OPAT unit was established at Lausanne University Hospital. We review here the experience of this new OPAT unit after 18 months of activity. Patient characteristics, clinical activities and outcomes were recorded prospectively. Need and acceptance was evaluated as number of OPAT courses administered and number of patients refusing OPAT. Safety and efficacy were evaluated as: (1) adverse events linked to antimicrobials and catheters, (2) re-admission to hospital, (3) rate of treatment failures and (4) mortality. Over 18 months, 179 courses of OPAT were administered. Acceptance was high with only four patients refusing OPAT. Urinary tract infections with resistant bacteria and musculoskeletal infections were the most common diagnoses. Self-administration of antibiotics using elastomeric pumps became rapidly the most frequently used approach. Sixteen patients presented with adverse events linked to antimicrobials and catheters. OPAT-related readmissions occurred in nine patients. The overall cure rate was 94 %. This study shows that OPAT is very well accepted by patients and medical staff, even in a setting which has not used this type of treatment approach until now. Self-administration using elastomeric pumps proved to be particularly useful, safe and efficient. OPAT offers a good alternative to hospitalisation for patients presenting with infections due to resistant bacteria that cannot be treated orally anymore and for difficult to treat infections.
机译:门诊肠外抗菌治疗(OPAT)已被认为是住院治疗的一种有用,具有成本效益和安全的替代方法,但是直到最近瑞士才出现正式的OPAT部门。 2013年12月,在洛桑大学医院成立了OPAT部门。经过18个月的活动,我们在这里回顾了这个新的OPAT部门的经验。前瞻性地记录患者的特征,临床活动和结局。将需求和接受程度评估为已开办的OPAT课程的数量和拒绝OPAT的患者数量。安全性和有效性评估为:(1)与抗菌素和导管相关的不良事件;(2)重新入院;(3)治疗失败率和(4)死亡率。在过去的18个月中,共管理了179个OPAT课程。接受率很高,只有四名患者拒绝接受OPAT。最常见的诊断是抗药性细菌感染的尿路感染和肌肉骨骼感染。使用弹性泵自行施用抗生素已迅速成为最常用的方法。 16名患者出现与抗生素和导管相关的不良事件。 9名患者发生了OPAT相关的再次入院。总治愈率为94%。这项研究表明,即使在至今尚未使用这种治疗方法的环境中,OPAT也已被患者和医护人员很好地接受。使用弹性泵的自我管理被证明是特别有用,安全和有效的。对于因无法再口服治疗且难以治疗的耐药细菌而感染的患者,OPAT为住院患者提供了很好的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号